0: Postmortem brain tissue samples from patients with schizophrenia, bipolar disorder, and control subjects were obtained from Fukushima Brain Bank at the Department of Neuropsychiatry, Fukushima Medical University; Brain Research Institute, Niigata University; and Choju Medical Institute Fukushimura Hospital, Toyohashi as described previously 29.
1: Use of postmortem human brain tissues for the present study was approved by the Ethics Committee of Fukushima Medical University and Niigata University, and complied with the Declaration of Helsinki and its later amendments.
2: All procedures were carried out with the informed written consent of the next of kin.
3: Detailed demographic information of brain tissues from 21 subjects with schizophrenia, 6 subjects with bipolar disorder and 22 control subjects used in this study (it was identical to first sample set in genotyping) was summarized in Table  1.
4: Each patient with schizophrenia and bipolar disorder fulfilled the diagnostic criteria established by the American Psychiatric Association (Diagnostic and Statistical Manual of Mental Disorders: DSM-IV).
5: For patients with schizophrenia, the daily dosage of antipsychotics prescribed during the 3 months immediately preceding death is shown as chlorpromazine-equivalent dose (mg/day, Table  1).
